Pricing Log in Create free account

Sonoma Pharmaceuticals, Inc. (SNOA) vs Universe Pharmaceuticals INC (UPC)

Sonoma Pharmaceuticals, Inc. and Universe Pharmaceuticals INC are both Drug Manufacturers Specialty & Generic companies. Universe Pharmaceuticals INC is the larger, with a market value of $7.0M against $5.1M — 1.4× the size. Universe Pharmaceuticals INC has the higher net margin (−6.42% vs −10.3%) and the higher return on invested capital (0.00% vs −70.0%). Across the 16 metrics below, Universe Pharmaceuticals INC leads on 12 and Sonoma Pharmaceuticals, Inc. on 4.

Valuation

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.19 n/m 2.08
P/B 0.63 n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.86 8.52 12.22
EV/Sales (0.05) (0.24) 2.87
Earnings yield (112.96%) (105.04%) (15.94%)
Free cash flow yield (63.92%) 0.00% 0.00%

Profitability

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
Gross margin 38.91% 49.77% 53.51%
Operating margin (6.41%) 0.00% 0.00%
Net margin (10.33%) (6.42%) (2.45%)
Free cash flow margin (12.11%) 0.00% 0.00%
Return on equity (42.52%) 0.00% (0.80%)
Return on assets (13.85%) 0.00% (1.67%)
Return on invested capital (69.96%) 0.00% 0.00%

Growth

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 47.00% — 5.22%
EPS growth (last fiscal year) 32.26% 98.71% 42.91%
Revenue growth, 5-year CAGR 0.95% (10.27%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.17 0.04
Current ratio 2.99 4.05 2.41
Net debt to EBITDA 1.03 10.15 1.01

Dividend

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric SNOA UPC Drug Manufacturers Specialty & Generic median
Market cap 5.13m 7.04m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack